Home / News
-
-
On July 28, Innovita Biological Technology Co., Ltd. was listed on the SSE STAR Market with the stock code of 688253. Its issue price was CNY 26.06 per share. After the opening, the market value exceeded CNY 4.6 billion.2022-07-28View More
-
-
AstraZeneca's acquisition of TeneoTwo will give the company access to its clinical-stage T-cell engager, TNB-486, strengthening their hematological cancer pipeline.2022-07-28View More
-
-
Roche¡¯s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.2022-07-28View More
-
-
On July 26, 2022, China Securities Regulatory Commission approved MGI¡¯s IPO registration on the sci-tech innovation board.2022-07-27View More
-
-
3M (NYSE: MMM) today announced its intent to spin off its Health Care business, resulting in two world-class public companies well positioned to pursue their respective growth plans.2022-07-27View More
-
-
DiaSorin said Friday it received 501(k) clearance from the US Food and Drug Administration to market its Liaison MeMed BV, a high-throughput immune-response assay that can differentiate between bacterial and viral infections.2022-07-27View More
-
-
Qiagen on Tuesday afternoon reported strong year-over-year sales growth in its core non-COVID-related product portfolio, prompting the company to raise its full-year revenue and earnings guidance even as its COVID-19-related business remains volatile.2022-07-27View More
-
-
On July 23, 2022, the China Enterprise Evaluation Association released the "2021 China Top 500 New Economy Enterprises" list. China's Top 500 New Economy Enterprises is hosted by the China Enterprise Evaluation Association2022-07-26View More
-
-
Ginkgo Bioworks said on Monday that it has entered into a definitive agreement to acquire Zymergen in an all-stock deal.2022-07-26View More
-
-
Chinese sequencing tech company GeneMind Biosciences said earlier this month that its single-molecule DNA sequencer, GenoCare 1600 (originally developed by Direct Genomics), has been approved by China's National Medical Products Administration (NMPA) for clinical and diagnostic applications.2022-07-26View More
-
-
Recently, the Wondfo Biotech COVID-19 Antigen Detection Kit (Immunochromatography Method) was included in the WHO (World Health Organization) list for emergency use by the WHO, which can be purchased by other countries and regions.2022-07-25View More
-
-
PamGene International BV said on Thursday that it has obtained CE-IVD registration for its IOpener-NSCLC blood test to help guide immunotherapy in advanced-stage cancer patients.2022-07-25View More
-
-
The US Food and Drug Administration this week granted Emergency Use Authorization for a molecular SARS-CoV-2 test from Predicine.2022-07-25View More
-
-
The semi-annual report shows that Maccura spent 166 million CNY to complete the acquisition of 100% equity of Beijing Dawei Biotechnology Co., Ltd. (hereinafter referred to as " Dawei ").2022-07-22View More
-
-
Danaher's diversification of its business conglomerate has led to increased stability and second quarter revenue growth in the face of headwinds, company executives said on Thursday2022-07-22View More
-
-
Roche on Thursday reported its Diagnostics division revenues grew 10 percent year over year in the first half of the year but said that it expects the momentum from COVID-19 testing-related sales to slow throughout the rest of the year.2022-07-22View More
-
-
Recently, Wondfo's 2019-nCoV Antigen Test (Lateral Flow Method) is listed by WHO (World Health Organization) for emergency use listing (EUL), available for purchase in other countries and regions in worldwide.2022-07-21View More
-
-
Danaher subsidiary Beckman Coulter and cell morphology firm Scopio Labs announced on Wednesday a deal to expand Scopio's digital blood smear platforms.2022-07-21View More
-
-
Abbott said on Wednesday that COVID-19 testing demand has continued throughout its second quarter, driving its Diagnostics business revenues up 33 percent year over year.2022-07-21View More
-
-
On July 17, a reporter from People¡¯s Daily Health Channel learned from Guangdong Academy of Sciences that Professor Wu Wenming, deputy director of the National Medical and Health Device Engineering Technology Research Center and scholar of the Hundred Talents Program of the Chinese Academy of Sciences2022-07-20View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.